ALDER BIOPHARMACEUTICALS INC (24) | Human Resources (7)

Browse by Subcategory

Recent Contracts

Alder BioPharmaceuticals, Inc. Executive Severance Benefit Plan, effective October 18, 2019 (Filed With SEC on October 22, 2019)
Form of Stock Option Grant Notice and Option Agreement for the 2014 Equity Incentive Plan (for Annual Grants) (Filed With SEC on August 6, 2019)
Transition and Consulting Agreement between Alder BioPharmaceuticals, Inc. and John A. Latham, Ph.D. dated March 28, 2019 (Filed With SEC on May 2, 2019)
Compensation Information for Non-Employee Directors (Filed With SEC on May 2, 2019)
Transition Agreement between Alder BioPharmaceuticals, Inc. and Elisabeth A. Sandoval, dated November 2, 2018 (Filed With SEC on February 25, 2019)
Form of Stock Option Grant Notice and Option Agreement for the 2014 Equity Incentive Plan (for Initial Grants) (Filed With SEC on August 6, 2019)
Amendment to Offer Letter between Alder BioPharmaceuticals, Inc. and Carlos E. Campoy dated February 7, 2019. X 10.32+ Amended and Restated Executive Severance Benefit Plan (Filed With SEC on February 25, 2019)